Roche announced on Thursday that it has entered a share purchase agreement to acquire 100 percent of the outstanding shares of the TIB Molbiol Group.

On September 9, 2021, Agilent successfully delivered the first batch of SureSelect targeted capture probe products produced in China at its Hangzhou production base.

Foundation Medicine announced on Wednesday that it is collaborating with Science 37 to create a home-based clinical trial model for patients who can't travel to clinical trial sites.

Alamar Biosciences said on Wednesday that it has closed an $80 million Series B financing round, bringing its total funding to $110 million.

On September 8, 2021, Hangzhou Biotest Biotech Co., Ltd. was listed on SSE STAR Market. Stock code: 688767. The issue price is 34.55 yuan/share, and the opening price is 80.50 yuan/share.

Siemens Healthineers said Tuesday that the TüV Rheinland certification agency has certified its first products under the new European In Vitro Diagnostic Regulation.

Illumina and Merck provided more details on Tuesday about their partnership to develop and commercialize tests that gauge genetic mutations involved in homologous recombination deficiency, or HRD, and identify best responders to PARP inhibitors.

Sinopharm Foreign Trade (Beijing) Co., Ltd., subsidiary of China National Pharmaceutical Group Corporation signed the agency agreement for the “Immunocytochemical Detection Kit of p16/Ki-67” (hereinafter referred to as "p16/Ki-67”) with MXB Biotechnologies Co., Ltd., subsidiary of BSBE.

Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has signed a new major distributor agreement that will speed the commercial roll-out of its breakthrough rapid genetic testing solutions across Spain.

The proposed acquisition comes shortly after a court ordered Hill-Rom to complete its acquisition of Bardy Diagnostics, a cardiac monitoring specialist, for $375 million.

According to "Medical Device and Diagnostics Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type and Services and Geography", the market is expected to reach US$ 20,336.08 million in 2028 from US$ 12,314.65 million in 2021.

QIAGEN to join the DAX on September 20, 2021, the effective date for changes in index composition. QIAGEN to remain in TecDAX comprised of the 30 largest German technology sector companies.

Mindray has purchased 3,048,662 shares through the stock repurchase special securities account, accounting for 0.2508% of the total share capital of the company. The total amount paid is almost 1 Billon CNY.

China has announced plans to set up a third stock exchange to serve small and medium-sized businesses.

Digital health technology firm Cue Health is seeking up to $100 million in a proposed initial public offering, it said in a registration statement filed on Wednesday with the US Securities and Exchange Commission.